Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2012, Article ID 637452, 11 pages
http://dx.doi.org/10.1155/2012/637452
Research Article

TNF-Alpha in the Locomotor System beyond Joints: High Degree of Involvement in Myositis in a Rabbit Model

1Anatomy Section, Department of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden
2Department of Physical Therapies, Australian Institute of Sport, Belconnen, ACT 2616, Australia
3School of Primary Health Care, Monash University, Frankston, VIC 3199, Australia

Received 29 August 2011; Revised 3 November 2011; Accepted 4 December 2011

Academic Editor: Simone Appenzeller

Copyright © 2012 Sture Forsgren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Feldmann, F. M. Brennan, and R. N. Maini, “Role of cytokines in rheumatoid arthritis,” Annual Review of Immunology, vol. 14, pp. 397–440, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. H. van Deventer, “Tumor necrosis factor and Crohn's disease,” Gut, vol. 40, pp. 443–448, 1997. View at Google Scholar
  3. G. Sethi, B. Sung, A. B. Kunnumakkara, and B. B. Aggarwal, “Targeting TNF for treatment of cancer and autoimmunity,” Advances in Experimental Medicine and Biology, vol. 647, pp. 37–51, 2009. View at Google Scholar · View at Scopus
  4. P. R. Ling, J. H. Schwartz, and B. R. Bistrian, “Mechanisms of host wasting induced by administration of cytokines in rats,” American Journal of Physiology, vol. 272, no. 3, pp. E333–E339, 1997. View at Google Scholar · View at Scopus
  5. R. A. Collins and M. D. Grounds, “The role of tumor necrosis factor-alpha (TNF-α) in skeletal muscle regeneration: studies in TNF-α(-/-) and TNF-α(-/-)/LT-α(-/-) mice,” Journal of Histochemistry and Cytochemistry, vol. 49, no. 8, pp. 989–1001, 2001. View at Google Scholar · View at Scopus
  6. M. B. Elliott, A. E. Barr, B. D. Clark, M. Amin, S. Amin, and M. F. Barbe, “High force reaching task induces widespread inflammation, increased spinal cord neurochemicals and neuropathic pain,” Neuroscience, vol. 158, no. 2, pp. 922–931, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Peterson, K. D. Feeback, J. H. Baas, and F. X. Pizza, “Tumor necrosis factor-α promotes the accumulation of neutrophils and macrophages in skeletal muscle,” Journal of Applied Physiology, vol. 101, no. 5, pp. 1394–1399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. L. Warren, T. Hulderman, N. Jensen et al., “Physiological role of tumor necrosis factor alpha in traumatic muscle injury,” The FASEB Journal, vol. 16, no. 12, pp. 1630–1632, 2002. View at Google Scholar · View at Scopus
  9. J. G. Tidball, “Inflammatory processes in muscle injury and repair,” American Journal of Physiology, vol. 288, no. 2, pp. R345–R353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. D. P. Kotler, “Cachexia,” Annals of Internal Medicine, vol. 133, no. 8, pp. 622–634, 2000. View at Google Scholar · View at Scopus
  11. G. D. Summers, G. S. Metsios, A. Stavropoulos-Kalinoglou, and G. D. Kitas, “Rheumatoid cachexia and cardiovascular disease,” Nature Reviews Rheumatology, vol. 6, no. 8, pp. 445–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Petersen, P. Plomgaard, C. P. Fischer, T. Ibfelt, B. K. Pedersen, and G. van Hall, “Acute moderate elevation of TNF-α does not affect systemic and skeletal muscle protein turnover in healthy humans,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 294–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. C. Reinecker, M. Steffen, T. Witthoeft et al., “Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease,” Clinical and Experimental Immunology, vol. 94, no. 1, pp. 174–181, 1993. View at Google Scholar · View at Scopus
  14. S. C. Bischoff, A. Lorentz, S. Schwengberg, G. Weier, R. Raab, and M. P. Manns, “Mast cells are an important cellular source of tumour necrosis factor in human intestinal tissue,” Gut, vol. 44, no. 5, pp. 643–652, 1999. View at Google Scholar · View at Scopus
  15. H. Shibata, Y. Abe, Y. Yoshioka et al., “Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2,” Cytokine, vol. 50, no. 1, pp. 75–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Reikerås, “Immune depression in musculoskeletal trauma,” Inflammation Research, vol. 59, no. 6, pp. 409–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Tews and H. H. Goebel, “Cytokine expression profile in idiopathic inflammatory myopathies,” Journal of Neuropathology and Experimental Neurology, vol. 55, no. 3, pp. 342–347, 1996. View at Google Scholar · View at Scopus
  18. J. L. De Bleecker, V. I. Meire, W. Declercq, and E. H. van Aken, “Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies,” Neuromuscular Disorders, vol. 9, no. 4, pp. 239–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. M. C. Dalakas, “Review: an update on inflammatory and autoimmune myopathies,” Neuropathology and Applied Neurobiology, vol. 37, no. 3, pp. 226–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. G. Radley, M. J. Davies, and M. D. Grounds, “Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment,” Neuromuscular Disorders, vol. 18, no. 3, pp. 227–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. T. Piers, T. Lavin, H. G. Radley-Crabb, A. J. Bakker, M. D. Grounds, and G. J. Pinniger, “Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice,” Neuromuscular Disorders, vol. 21, no. 2, pp. 132–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Mastaglia, “Inflammatory muscle diseases,” Neurology India, vol. 56, no. 3, pp. 263–270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H. K. Tsou, C. M. Su, H. T. Chen et al., “Integrin-linked kinase is involved in TNF-α-induced inducible nitric-oxide synthase expression in myoblasts,” Journal of Cellular Biochemistry, vol. 109, no. 6, pp. 1244–1253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Spang, A. Scott, P. Danielson, R. Lorentzon, and S. Forsgren, “VGluT2 and NMDAR1 expression in cells in the inflammatory infiltrates in experimentally induced myositis: evidence of local glutamate signaling suggests autocrine/paracrine effects in an overuse injury model,” Inflammation, vol. 35, no. 1, pp. 39–48, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Dennett and H. J. H. Fry, “Overuse syndrome: a muscle biopsy study,” The Lancet, vol. 23, no. 8591, pp. 905–908, 1988. View at Google Scholar · View at Scopus
  26. M. F. Barbe and A. E. Barr, “Inflammation and the pathophysiology of work-related musculoskeletal disorders,” Brain, Behavior, and Immunity, vol. 20, no. 5, pp. 423–429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. C. Cuesta, L. Quintero, H. Pons, and H. Suarez-Roca, “Substance P and calcitonin gene-related peptide increase IL-1β, IL-6 and TNFα secretion from human peripheral blood mononuclear cells,” Neurochemistry International, vol. 40, no. 4, pp. 301–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Backman, L. Boquist, and J. Friden, “Chronic Achilles paratenonitis with tendinosis: an experimental model in the rabbit,” Journal of Orthopaedic Research, vol. 8, no. 4, pp. 541–547, 1990. View at Google Scholar · View at Scopus
  29. G. Andersson, S. Forsgren, A. Scott et al., “Tenocyte hypercellularity and vascular proliferation in a rabbit model of tendinopathy: contralateral effects suggest the involvement of central neuronal mechanisms,” British Journal of Sports Medicine, vol. 45, no. 5, pp. 399–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Backman, J. Friden, and A. Widmark, “Blood flow in chronic Achilles tendinosis: radioactive microsphere study in rabbits,” Acta Orthopaedica Scandinavica, vol. 62, no. 4, pp. 386–387, 1991. View at Google Scholar · View at Scopus
  31. M. Hansson and S. Forsgren, “Immunoreactive atrial and brain natriuretic peptides are co-localized in Purkinje fibres but not in the innervation of the bovine heart conduction system,” Histochemical Journal, vol. 27, no. 3, pp. 222–230, 1995. View at Google Scholar · View at Scopus
  32. G. S. Rees, C. K. Gee, H. L. Ward et al., “Rat tumour necrosis factor-α: expression in recombinant Pichia pastoris, purification, characterization and development of a novel ELISA,” European Cytokine Network, vol. 10, no. 3, pp. 383–392, 1999. View at Google Scholar · View at Scopus
  33. A. Panoskaltsis-Mortari and R. P. Bucy, “In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts,” BioTechniques, vol. 18, no. 2, pp. 300–307, 1995. View at Google Scholar · View at Scopus
  34. P. Danielson, H. Alfredson, and S. Forsgren, “In situ hybridization studies confirming recent findings of the existence of a local nonneuronal catecholamine production in human patellar tendinosis,” Microscopy Research and Technique, vol. 70, no. 10, pp. 908–911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Jönsson, Ö. Norrgård, and S. Forsgren, “Presence of a marked nonneuronal cholinergic system in human colon: study of normal colon and colon in ulcerative colitis,” Inflammatory Bowel Diseases, vol. 13, no. 11, pp. 1347–1356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Bjur, P. Danielson, H. Alfredson, and S. Forsgren, “Immunohistochemical and in situ hybridization observations favor a local catecholamine production in the human Achilles tendon,” Histology and Histopathology, vol. 23, no. 1–3, pp. 197–208, 2008. View at Google Scholar · View at Scopus
  37. A. A. Grom, K. J. Murray, L. Luyrink et al., “Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy,” Arthritis and Rheumatism, vol. 39, no. 10, pp. 1703–1710, 1996. View at Google Scholar · View at Scopus
  38. M. C. Dalakas and R. Hohlfeld, “Polymyositis and dermatomyositis,” The Lancet, vol. 362, no. 9388, pp. 971–982, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. K. B. Stone, C. V. Oddis, N. Fertig et al., “Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy,” Arthritis and Rheumatism, vol. 56, no. 9, pp. 3125–3131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Efthimiou, “Tumor necrosis factor-α in inflammatory myopathies: pathophysiology and therapeutic implications,” Seminars in Arthritis and Rheumatism, vol. 36, no. 3, pp. 168–172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kondo, Y. Murakawa, N. Harashima, S. Kobayashi, S. Yamaguchi, and M. Harada, “Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies,” Immunology, vol. 128, no. 1, pp. e589–e599, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. D. S. Tews and H. H. Goebel, “Cell death and oxidative damage in inflammatory myopathies,” Clinical Immunology and Immunopathology, vol. 87, no. 3, pp. 240–247, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. E. A. Flores, B. R. Bistrian, J. J. Pomposelli, C. A. Dinarello, G. L. Blackburn, and N. W. Istfan, “Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat: a synergistic effect with interleukin 1,” Journal of Clinical Investigation, vol. 83, no. 5, pp. 1614–1622, 1989. View at Google Scholar · View at Scopus
  44. R. A. Frost, C. H. Lang, and M. C. Gelato, “Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis,” Endocrinology, vol. 138, no. 10, pp. 4153–4159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. B. J. Mullen, R. B. S. Harris, J. S. Patton, and R. J. Martin, “Recombinant tumor necrosis factor-α chronically administered in rats: lack of cachectic effect,” Proceedings of the Society for Experimental Biology and Medicine, vol. 193, no. 4, pp. 318–325, 1990. View at Google Scholar · View at Scopus
  46. B. Echtenacher, D. N. Männel, and L. Hültner, “Critical protective role of mast cells in a model of acute septic peritonitis,” Nature, vol. 381, no. 6577, pp. 75–77, 1996. View at Publisher · View at Google Scholar
  47. S. E. Chen, B. Jin, and Y. P. Li, “TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK,” American Journal of Physiology, vol. 292, no. 5, pp. C1660–C1671, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. A. N. Baer, “Advances in the therapy of idiopathic inflammatory myopathies,” Current Opinion in Rheumatology, vol. 18, no. 3, pp. 236–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Chevrel, C. Granet, and P. Miossec, “Contribution of tumour necrosis factor α and interleukin (IL) 1β to IL6 production, NF-κB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1257–1262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. E. Kalovidouris and Z. Plotkin, “Synergistic cytotoxic effect of interferon-γ and tumor necrosis factor- α on cultured human muscle cells,” Journal of Rheumatology, vol. 22, no. 9, pp. 1698–1703, 1995. View at Google Scholar · View at Scopus
  51. S. Rani, M. F. Barbe, A. E. Barr, and J. Litivn, “Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping,” Journal of Cellular Physiology, vol. 225, no. 1, pp. 152–167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. R. L. Lieber and J. Fridén, “Mechanisms of muscle injury gleaned from animal models,” American Journal of Physical Medicine and Rehabilitation, vol. 81, no. 11, pp. S70–S79, 2002. View at Publisher · View at Google Scholar
  53. S. R. Ytterberg, “The relationship of infectious agents to inflammatory myositis,” Rheumatic Disease Clinics of North America, vol. 20, no. 4, pp. 995–1015, 1994. View at Google Scholar · View at Scopus
  54. O. Paciello, S. Wojcik, L. Gradoni et al., “Syrian hamster infected with Leishmania infantum: a new experimental model for inflammatory myopathies,” Muscle and Nerve, vol. 41, no. 3, pp. 355–361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. N. L. Rosenberg, “Experimental models of inflammatory myopathies,” Bailliere"s Clinical Neurology, vol. 2, no. 3, pp. 693–715, 1993. View at Google Scholar · View at Scopus
  56. Y. Katsumata and D. P. Ascherman, “Animal models in myositis,” Current Opinion in Rheumatology, vol. 20, no. 6, pp. 681–685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Vitadello, A. Doria, E. Tarricone, A. Ghirardello, and L. Gorza, “Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation,” Arthritis Research and Therapy, vol. 12, no. 2, article R52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. J. G. Tidball and M. Wehling-Henricks, “Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis,” Current Opinion in Rheumatology, vol. 17, no. 6, pp. 707–713, 2005. View at Publisher · View at Google Scholar · View at Scopus